Clinical Trials Directory

Trials / Completed

CompletedNCT00885053

Fish Oil and Inflammation in Overweight Subjects

The Effect of Acute and Short-term Intervention With Fish Oil on Overweight Subjects - Focus on Inflammation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Aalborg University Hospital · Academic / Other
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the effects of acute and short-term intervention with fish oil on inflammatory markers in overweight subjects.

Detailed description

Being overweight is associated with metabolic syndrome, cardiovascular disease, and diabetes mellitus (type 2). Adipose tissue can be regarded as an active organ, which produces an array of inflammatory mediators. This creates a state of chronic low-grade inflammation. Inflammation has been proven to be a key element in the development of atherosclerotic plaques. The marine n-3 polyunsaturated fatty acids (PUFAs) have beneficial effects on cardiovascular disease. These effects are partly attributed to the anti-inflammatory effect of the n-3 PUFAs. Previous studies have shown an anti-inflammatory effect of n-3 PUFAs in overweight subjects, but the studies have been conducted with a high daily dose of n-3 PUFA. We want to examine the effect of a lower dose of 1 g n-3 PUFA/day (the dose recommended by the Danish Heart Foundation). The study is randomized, placebo-controlled and double blinded. Fifty subjects aged 30 - 75 years (postmenopausal women; waist circumference \> 80 cm and men; waist circumference \> 94 cm) will be included. Blood samples and fatty tissue biopsies will be collected at baseline, after 1 day and after 6 weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTfish oilCapsules. Approximately 1000 mg n-3 PUFA daily. One day + 6 weeks
DIETARY_SUPPLEMENTolive oilCapsules. Approximately 1 g olive oil daily. One day + 6 weeks

Timeline

Start date
2009-04-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2009-04-21
Last updated
2010-01-26

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00885053. Inclusion in this directory is not an endorsement.